DDReg Pharma- Consulting in regulatory affairs and drug safety

  Expanding into highly regulated markets like the European Union and the United Kingdom offers significant commercial opportunities   but it also comes with strict regulatory expectations. Even small gaps in technical documentation, manufacturing data, or submission structure can delay approvals or trigger regulatory queries. This is where regulatory gap analysis becomes essential. Regulatory gap analysis is a systematic review of existing product data, dossiers, and processes to identify discrepancies between what regulators require and what the sponsor currently has. It ensures that clinical, non-clinical, and Chemistry, Manufacturing, and Controls (CMC) information aligns with regional guidelines before submission. Addressing these gaps early helps companies avoid costly rework, delays, and compliance risks. This proactive approach is increasingly important as regulators use structured data reviews and digital tools to identify inconsistencies and deficiencies in submissions. I...

Marketing authorization does not end a medicine’s safety evaluation. Once products enter real-world use, broader patient exposure and long-term treatment can reveal risks not fully identified in clinical trials. Regulators therefore rely on Post-Authorization Safety Studies (PASS) to address post-approval safety uncertainties. PASS are structured pharmacoepidemiological or clinical studies conducted to evaluate identified or potential risks, assess risk-minimization effectiveness, and generate real-world safety evidence. Across the EU, US, UK, and other major markets, mandatory PASS are now embedded in regulatory frameworks and enforced as legally binding obligations. Authorities increasingly assess not only study outcomes, but also protocol governance, reporting discipline, and inspection readiness. As a result, PASS has evolved from a post-approval formality into a critical component of lifecycle pharmacovigilance and approval sustainability. Read in detail here: Post-Authorization S...